# FDA 483 - QPS, LLC - January 30, 2026

Source: https://www.keypedia.com/records/483/qps-llc/e2c4cd42-7ab5-4d16-8d7f-1b2ef805d649

> FDA 483 for QPS, LLC on January 30, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: QPS, LLC
- Inspection Date: 2026-01-30
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: QPS, LLC, an analytical facility in Newark, DE, was inspected by the FDA, revealing two observations. The firm failed to adhere to its Standard Operating Procedures for sample analysis, specifically regarding repeated re-assays. Additionally, the firm maintained source records with discrepancies that prevented the complete reconstruction of method validation data.

## Related Documents

- [EIR - 2013-06-21](https://www.keypedia.com/records/eir/qps-llc/e301a288-74a0-4a95-8b2e-ae604d049983)
- [EIR - 2017-08-25](https://www.keypedia.com/records/eir/qps-llc/1b2e9db1-14e0-441e-8c20-99049da16522)
- [EIR - 2017-12-08](https://www.keypedia.com/records/eir/qps-llc/2f3e7437-cc79-416d-b36c-00cdab575f30)
- [EIR - 2019-01-16](https://www.keypedia.com/records/eir/qps-llc/7b72e465-0f6f-4189-ba73-ecb7a607d328)
- [483 - 2026-01-30](https://www.keypedia.com/records/483/qps-llc/ed6dd8df-3c88-4205-9863-92f19636db28)

## Related Officers

- [Sylvestre K. Dossou](https://www.keypedia.com/people/sylvestre-k-dossou/962f9277-7643-4f66-add9-1c3553fa1c14)

Company: https://www.keypedia.com/companies/qps-llc/dd921aef-3600-420b-b84d-512c0675e45e

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8